Clinical Trial Update: A Study of How CagriSema Works on Appetite in People With Excess Body Weight [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating how the CagriSema combination affects appetite in adults with overweight or obesity; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• CagriSema (cagrilintide/semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED